Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer. [electronic resource]
Producer: 20111118Description: 1146-51 p. digitalISSN:- 1879-0852
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Camptothecin -- administration & dosage
- Cohort Studies
- Disease Progression
- Docetaxel
- Esophageal Neoplasms -- drug therapy
- Female
- Humans
- Irinotecan
- Male
- Middle Aged
- Prognosis
- Retrospective Studies
- Stomach Neoplasms -- drug therapy
- Taxoids -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.